Ashina M, Mitsikostas DD, Ramirez Campos V, Barash S, et al. Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis. Headache 2023 Nov 13. doi: 10.1111/head.14651.
PMID: 37955395